Tuberculosis drug serum levels.
Open Access
- 15 August 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (4) , 584-585
- https://doi.org/10.1086/322706
Abstract
Sir—The fine paper by Narita and colleagues [1] does not show a direct correlation between the serum concentrations of the tuberculosis drugs and the recurrence of tuberculosis disease. It is possible that the use of different break-point values (e.g., one-half of the target ranges) might have yielded different results. Ongoing research sponsored by the Centers for Disease Control and Prevention (Atlanta) suggests that, in certain situations, low serum concentrations of the tuberculosis drugs are associated with worse treatment outcomes. Some of these data were presented at the annual meeting of the American Thoracic Society in May 2001 [2, 3]. The available data suggest that failure of tuberculosis treatment or recurrence of disease results from a complex and poorly understood combination of factors that likely varies from patient to patient. The use of antibiotic serum concentrations rarely has perfect predictive value to guide the choice of drug dosage [4-10]. I would like to suggest an approach to the use of antibiotic serum concentrations that may be useful.Keywords
This publication has 12 references indexed in Scilit:
- Tuberculosis Recurrence: Multivariate Analysis of Serum Levels of Tuberculosis Drugs, Human Immunodeficiency Virus Status, and Other Risk FactorsClinical Infectious Diseases, 2001
- Goal-Oriented, Model-Based Drug Regimens: Setting Individualized Goals for Each PatientTherapeutic Drug Monitoring, 2000
- Once Daily Aminoglycoside TherapyClinical Pharmacokinetics, 1999
- Methodological Issues in Pharmacokinetic-Pharmacodynamic ModellingClinical Pharmacokinetics, 1998
- USING THERAPEUTIC DRUG MONITORING TO DOSE THE ANTIMYCOBACTERIAL DRUGSClinics in Chest Medicine, 1997
- Drug Malabsorption and Resistant Tuberculosis in HIV-Infected PatientsNew England Journal of Medicine, 1995
- Editorial: Monitoring Serum Vancomycin Levels: Climbing the Mountain Because It Is There?Clinical Infectious Diseases, 1994
- Malabsorption of Antimycobacterial MedicationsNew England Journal of Medicine, 1993
- A Critical Reevaluation of the "Therapeutic Range" of AminoglycosidesClinical Infectious Diseases, 1992
- Why Monitor Serum Levels of Gentamicin?Clinical Pharmacokinetics, 1978